Skip to content

MUC16 in Bladder Cancer

Published: July 27, 2026Updated: August 25, 2026

MUC16 is a biomarker that measures the level of the MUC16 protein in the blood, which is often elevated in bladder cancer patients. It is used for monitoring disease progression and treatment response.

Quick summary

MUC16 is a blood-based biomarker for monitoring bladder cancer.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 25, 2026Editorial policy

Key facts at a glance

Units
U/mL
Clinical utility
monitoring
Result kind
quantitative
FDA-cleared
Roche CA-125, Abbott CA-125
interpretation: {"text":"MUC16 levels within the range of 0–30 U/mL are considered normal and suggest no current evidence of active bladder cancer.","label":"Normal"}; {"text":"Levels above 30 U/mL may indicate the presence of bladder cancer or disease progression, necessitating further clinical evaluation.","label":"Elevated"}

MUC16, also known as CA-125, is a high molecular weight glycoprotein that is overexpressed in various cancers, including bladder cancer. Elevated levels of MUC16 in the blood can indicate the presence of cancer cells and are often used to monitor disease activity.

The reference range for MUC16 in the context of bladder cancer monitoring is typically between 0–30 U/mL. Levels above this range may suggest active disease or recurrence, prompting further investigation and potential adjustment of treatment strategies.

While MUC16 is not specific to bladder cancer, its utility in oncology lies in its ability to provide a non-invasive method for tracking disease progression and treatment effectiveness. It is often used in conjunction with other diagnostic tools for a comprehensive evaluation.

Frequently asked questions

What is the role of MUC16 in bladder cancer?
MUC16 serves as a biomarker for monitoring disease activity and treatment response in bladder cancer patients.
How is MUC16 measured?
MUC16 is measured through a blood test, with levels typically reported in U/mL.
  1. 1
    MUC16 (CA-125) as a Biomarker for Bladder CancerSource
  2. 2
    Clinical Utility of MUC16 in OncologySource

Click any link to access the full source. PubMed Central (PMC) links provide free full-text access.

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 25, 2026. · Read our editorial policy